ROMVIMZA
LIVE

Serial Number

98238958

Owner

Deciphera Pharmaceuticals, LLC

Attorney

Karen Won

First Use Date

Feb 20, 2025

Filing Date

Oct 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ROMVIMZA Trademark

Serial Number: 98238958 • Registration: 8061589

ROMVIMZA is a trademark filed by Deciphera Pharmaceuticals, LLC on October 25, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Deciphera Pharmaceuticals, LLC (18 trademarks)

200 Smith Street
Waltham, MA 02451

Entity Type: 16

Trademark Details

Filing Date

October 25, 2023

Registration Date

December 9, 2025

First Use Anywhere

February 20, 2025

First Use in Commerce

February 20, 2025

Published for Opposition

May 28, 2024

Goods & Services

Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 9, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 15, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 15, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 29, 2025 SUPC
USE AMENDMENT FILED
Jun 17, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 17, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 8, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 8, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 8, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 23, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 20, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 13, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 12, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 31, 2023 NWOS
NEW APPLICATION ENTERED
Oct 28, 2023 NWAP